1. Home
  2. TRVI vs PRDO Comparison

TRVI vs PRDO Comparison

Compare TRVI & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

SELL

Current Price

$12.50

Market Cap

1.8B

Sector

Health Care

ML Signal

SELL

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$32.69

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVI
PRDO
Founded
2011
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
TRVI
PRDO
Price
$12.50
$32.69
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $28.18
N/A
AVG Volume (30 Days)
★ 2.5M
441.0K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
★ 2.01%
EPS Growth
★ 31.91
10.50
EPS
N/A
★ 1.60
Revenue
N/A
★ $581,296,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
N/A
$2.98
P/E Ratio
★ N/A
$21.17
Revenue Growth
★ N/A
N/A
52 Week Low
$9.82
$26.66
52 Week High
$20.22
$38.50

Technical Indicators

Market Signals
Indicator
TRVI
PRDO
Relative Strength Index (RSI) 36.03 48.14
Support Level $11.70 $31.40
Resistance Level $13.55 $32.98
Average True Range (ATR) 0.66 0.87
MACD 0.13 0.01
Stochastic Oscillator 44.81 31.31

Price Performance

Historical Comparison
TRVI
PRDO

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

Share on Social Networks: